$2.67
-0.40-13.19%
最終更新: Oct 20, 4:40 AM
$2.57
-0.50-16.29%
Benzinga
Benzinga
Benzinga
火曜日, 10 20
NeuroSense Therapeutics Ltd
NRSNNASDAQ
PRO
Benzinga
© 2026 Benzinga | All Rights Reserved
NeuroSense Therapeutics (NRSN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | H1 '26 | H1 '25 | Q4 '24 | Q3 '24 | FY '25 |
|---|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||||
| Estimate | $-0.08 | $-2.60 | — | $-3.20 | $-8.00 |
| Actual | $-2.10 | $-3.80 | $-1.20 | $-2.20 | $-8.80 |
| Surprise | -2525.0% | -46.2% | — | +31.3% | -10.0% |
| Revenue | |||||
| Estimate | $514000 | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 | $0 |
| Surprise | -100.0% | — | — | — | — |
| Metric | FY '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $-4.11 |
| Revenue | |
| Consensus | $714000 |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| H1 | Sep 25, 2026 | $-2.10 | $-0.08 | -2525.0 % |
| FY | Mar 31, 2026 | $-8.80 | $-8.00 | -10.0 % |
| H1 | Aug 1, 2025 | $-3.80 | $-2.60 | -46.2 % |
| Q3 | Dec 18, 2024 | $-2.20 | $-3.20 | 31.3 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| H1 | Sep 25, 2026 | $0 | $514.00K | -100.0 % |